PhD Grant Assignment in Non-academic Environment-02/2026

Description

Offer Description: The company ICNAS PHARMA Unipessoal, Lda opens a call for the assignment of a PhD Grant in a non-academic environment, with the following characteristics: Number of grants: 1 Scientific field: Biomedical/Pharmaceutical Sciences; Nuclear Medicine; Radiopharmacy Activities planned:: Development and preclinical evaluation of novel radiopharmaceuticals for cancer diagnosis and therapy. Grant recipients: This grant is aimed at Master’s degree holders. Candidates should hold a Master degree in the scientific field described above or equivalent fields. Funding: The scholarship is funded by ICNAS PHARMA Unipessoal, Lda. Eligibility: Candidates must hold a Master’s degree in one of the scientific fields listed above or in a related field and enrolled in a PhD’s degree course in the scientific area of this call (Biomedical/Pharmaceutical Sciencs, Nuclear medicine or Radiopharmacy) Work plan: 1. Optimisation of radiolabelling conditions for novel compounds with specificity for molecular targets overexpressed in different types of cancer, and assessment of the radiochemical properties of the final products; 2. In vitro studies to assess the binding, specificity, cellular uptake and biological properties of the radiolabelled compounds; 3. In vivo evaluation in mouse models, including biodistribution and molecular imaging studies, complemented by ex vivo analyses of different tissues and organs; 4. Processing and interpretation of the results obtained, contributing to the selection and optimisation of the most promising candidates. Grant location: ICNAS PHARMA Unipessoal, Lda., located at the Instituto de Ciências Nucleares Aplicadas à Saúde, Pólo das Ciências da Saúde da Universidade de Coimbra, Coimbra Grant duration: 4 years. Renewal: The grant may be renewed, subject to the applicable conditions. Financial conditions: The grant provides a monthly stipend of €1,359.64, in accordance with the rates established by the Portuguese Foundation for Science and Technology (Fundação para a Ciência e a Tecnologia, FCT). The stipend will be paid by bank transfer at the end of each month. In addition, personal accident insurance will be provided. If the scholarship holder opts to enrol in the voluntary social security scheme, the corresponding contribution at the first contribution level will also be covered. The monthly stipend will remain unchanged throughout the entire scholarship period. Terms of the grant: The award of the grant does not establish or constitute an employment relationship. The grant must be undertaken on a full-time, exclusive basis, and the scholarship holder shall be subject to the status of research scholarship holder, in accordance with the FCT Research Fellowship Regulations (Regulation No. 950/2019, published in Diário da República , 2nd Series, No. 241, of 16 December 2019, as amended by Notice (extract) No. 412/2026/2, published in Diário da República , 2nd Series, No. 4, of 7 January 2026), the provisions available at https://www.fct.pt/financiamento/programas-de-financiamento/bolsas/ , and Law No. 40/2004 of 18 August, as amended by Decree-Law No. 233/2012 of 27 October. Selection procedure: Applications will be assessed on the basis of curriculum vitae and suitability for the position, weighted at 60% and 40%, respectively. Application requirements: Applicants must submit a motivation letter, a curriculum vitae including their academic record, copies of their academic degree certificates and proof of enrolment in a PhD degree. Application submission: Applications must be submitted either by email to [email protected] or by post to: ICNAS PHARMA Unipessoal, Lda Pólo Ciências da Saúde da Universidade de Coimbra Azinhaga de Santa Comba 3000-548 Coimbra Scientific supervisor: Antero José Pena Afonso de Abrunhosa Jury composition: Miguel de Sá e Sousa de Castelo Branco, Antero José Pena Afonso de Abrunhosa, and Professor Francisco José Cerqueira Alves Application deadline: 16/10/2026 a 30/10/2026 Publication

Sectors

Source

Source: euraxess.ec.europa.eu